Vaccines and Public Health
Adult immunization rates are falling short of national targets. Learn how global, federal, and state policies affect vaccination uptake. Leverage our findings to guide your strategies. Rely on our expertise commercializing novel and therapeutic vaccines.
Vaccine Exemptions and the Federal Government’s Role
With the number of measles cases rising across the country, FDA Commissioner Scott Gottlieb raised the prospect of federal intervention over exemptions to state-level immunization school-entry requirements. While not specifying what role the federal government would play, Gottlieb stated, “You could mandate certain rules about what is and isn’t permissible when it comes to allowing people to have exemptions.”
ACIP Recommendations Shift Pneumococcal Vaccination Patterns
New research from Avalere finds that the provision of pneumococcal conjugate vaccines increased immediately after ACIP’s 2014 recommendation to add the vaccine to the routine immunization schedule for older adults.
Are Health Plans the Future of Public Health?
The transition from old-guard payer to wellness company is underway–and moving rapidly.
Emerging Influenza Vaccine Technologies Stand to Improve Vaccination Rates
Nearly 80,000 people died during the 2017–2018 influenza season. Only 37% of adults were vaccinated. Several novel emerging products could make vaccination more accessible and effective, potentially reshaping the market and lowering influenza disease burden.
Lack of Clarity on Preventive Services Recommendations May Create Access Barriers
Ambiguous recommendations for preventive services are causing confusion among plans and providers on the clinically recommended preventive services that should be covered without cost sharing. A recent USPSTF recommendation on HIV prevention offers an opportunity to urge a recommending body to provide further clarity in its recommendation. Comments are due December 26.
Fewer Seniors Get Vaccinated as Their Out-of-Pocket Costs Increase
New research shows higher cost sharing for vaccines under Part D leads to fewer seniors getting vaccines. Immunization rates are higher for vaccines covered by Part D plans with lower cost sharing.
Reforming Medicare Vaccine Coverage to Reduce Barriers to Access
On June 14, Avalere experts came together with Cynthia Tudor, former Deputy Center Director of the Center for Medicare and Senior Advisor to Avalere, to discuss vaccine coverage and access challenges under Medicare.
Shifting Drugs from Medicare Part B to Part D: Learnings from Medicare Coverage of Vaccines
A proposed shift of Part B drugs into Part D could affect patient access and increase the burden on providers.
Webinar: Barriers to Access: Reforming Medicare Vaccine Coverage
Avalere experts discuss adult immunization rates in the United States and how the disparate coverage of vaccines under Medicare creates significant barriers to increasing adult immunization uptake.
State-Level Policies Can Play Key Role in Improving Adult Immunization Rates
States can pursue various policy opportunities to encourage vaccination and increase access to vaccines.
Emerging Opportunities to Drive Adult Immunization Through Quality
Quality measurement in the adult vaccine space has evolved rapidly. Recent advancements continue to propel efforts to drive adult immunization uptake.
Vaccine Coverage Requirements Vary by Market
Avalere has released a new white paper explaining the current insurance coverage requirements for vaccines and the laws that govern those requirements for the Medicare (Parts B and D), Medicaid, and commercial (group and individual) markets.
Pharmacist Immunization Authority Associated with Higher Seasonal Influenza Immunization Rates
Avalere recently partnered with the National Association of Chain Drug Stores (NACDS) to explore the role that pharmacists can play in the uptake of seasonal influenza immunizations.
Medicare Has the Potential to Avoid Preventable Illnesses by Encouraging Broader Coverage for Adult Vaccines
A new analysis by Avalere finds that, despite efforts by policymakers to encourage broader vaccination rates, Medicare enrollees have limited access to a set of 10 recommended vaccines without having to pay out-of-pocket (e.g., co-payments).